Whether you live in an apartment or house, or you just need to ensure that your house is free from EMFs There are plenty of ways you can reduce exposure. One of the easiest is to limit your use of electronic devices. It is also possible to use EMF blocker paint to block EMF radiation from entering your home. Another method to protect your house from EMF radiations is to use a shielding canopy for RF. This is a fabric made of net which contains EMF shielding and is used to prevent EMFs from entering rooms. Another option is to have your home equipped with an electrical enclosure. These enclosures are known as Faraday cages.
Several studies have shown studies have shown that nonionizing EMF produces antiproliferative effects on HCC cells. The mechanism of AM RF EMF's anticancer activity in vitro is believed to involve down-regulation of cancer stem cells. This may account for the long-term response seen in some patients with advanced HCC. However, the mechanism behind AM EMF's effects on patients suffering from cancer isn't evident.
Effects of AM RF EMFs on HCC tumour growth in vivo were examined in mice. The tumors were split in three different groups. One group did not have exposure to RF EMF. Another group of participants was subjected RF EMF at a frequency that is similar to the one used by humans. emf blockers was exposed to RF EMF with HCC-specific modulation frequencies. The impact of HCCMF on tumors was compared to that of RCF. The results indicated that cancers treated with HCCMF were significantly shrinking. However, the tumours treated with RCF didn't show evidence of tumour shrinkage.
The mechanism of cancer-specific AM RF EMF could be based on the fact that tumor cells require Cav3*2 type voltage calcium channels to promote proliferation and down-regulation. AM RF EMF's ability to inhibit proliferation on HCC cells is controlled by CACNA1H the protein that mediates tumour-specific Ca2+ influx. The results indicate that CACNA1H could have more broader implications for treatment and diagnosis of many cancers.
The tumors in the control group were not exposed to EMF from radiofrequency, and fed a standard mouse diet. The tumours in HCCMF HCCMF group were treated with Huh7 cells when they were 5 to 7 weeks old. The tumours were then euthanized after they had a high burden.
emf blockers of the three groups showed different growth curves. The HCCMF-treated tumors saw a significant reduction in tumour size after 8 weeks. However, the tumours which were treated by RCF did not show any signs of shrinkage. The difference was significant. The tumors treated with RCF had necrosis that is common in tumours that are exposed to RCF. The possibility is that this necrosis was due to an absence of oxygen in the larger cancers.
In conclusion, the findings indicate the fact that AM EMF has anticancer properties in vitro as well as in the vivo. emf blockers have shown the fact that AM RF EMF produces measurable tumour shrinkage for HCC patients. There is a possibility that AM RF EMF causes these effects due to CACNA1H which is a protein involved in the process of tissue-specific Ca2+ influx. Additionally, AM RF EMF may cause a lasting effect on the growth of HCC tumors in vivo.